423 related articles for article (PubMed ID: 24161452)
1. C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease.
Cubała WJ; Landowski J
J Affect Disord; 2014 Jan; 152-154():534-7. PubMed ID: 24161452
[TBL] [Abstract][Full Text] [Related]
2. Magnesium, C-reactive protein, and cortisol in drug-naïve patients with short illness-duration, first episode major depressive disorder: possible immunomodulatory role for magnesium.
Cubała WJ; Landowski J; Dziadziuszko M; Chrzanowska A; Wielgomas B
Magnes Res; 2016 Apr; 29(4):169-174. PubMed ID: 27965189
[TBL] [Abstract][Full Text] [Related]
3. Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubała WJ; Landowski J
J Affect Disord; 2014 Mar; 157():14-7. PubMed ID: 24581822
[TBL] [Abstract][Full Text] [Related]
4. Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubała WJ; Landowski J; Wielgomas B; Czarnowski W
J Affect Disord; 2014 Jun; 161():4-7. PubMed ID: 24751300
[TBL] [Abstract][Full Text] [Related]
5. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
Cubała WJ; Landowski J
J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
[TBL] [Abstract][Full Text] [Related]
6. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
[TBL] [Abstract][Full Text] [Related]
7. Salivary 5-hydroxyindole acetic acid (5-HIAA) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubala WJ; Landowski J; Chrzanowska A
Neuro Endocrinol Lett; 2014; 35(8):746-9. PubMed ID: 25702305
[TBL] [Abstract][Full Text] [Related]
8. Magnesium in drug-naïve patients with a short-duration, first episode of major depressive disorder: impact on psychopathological features.
Cubała WJ; Landowski J; Szyszko M; Czarnowski W
Magnes Res; 2013; 26(4):192-8. PubMed ID: 24509052
[TBL] [Abstract][Full Text] [Related]
9. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
[TBL] [Abstract][Full Text] [Related]
10. Zinc in drug-naïve patients with short-illness-duration first episode major depressive disorder: impact on psychopathological features.
Cubala WJ; Landowski J; Szyszko M; Wielgomas B
Neuro Endocrinol Lett; 2014; 35(8):741-5. PubMed ID: 25702304
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis.
Zhang C; Dong Y; Li S; Li M; Gao Y; Liu Y; Liu X; Zhou C; Li J
Asia Pac Psychiatry; 2024 Mar; 16(1):e12552. PubMed ID: 38348641
[TBL] [Abstract][Full Text] [Related]
12. Cognitive functioning and cortisol profiles in first episode major depression.
Hansson PB; Murison R; Lund A; Hammar Å
Scand J Psychol; 2015 Aug; 56(4):379-83. PubMed ID: 26032571
[TBL] [Abstract][Full Text] [Related]
13. Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder.
Pochigaeva K; Druzhkova T; Yakovlev A; Onufriev M; Grishkina M; Chepelev A; Guekht A; Gulyaeva N
Metab Brain Dis; 2017 Apr; 32(2):577-583. PubMed ID: 28064407
[TBL] [Abstract][Full Text] [Related]
14. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.
Tanaka Y; Ishitobi Y; Maruyama Y; Kawano A; Ando T; Okamoto S; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Hanada H; Kodama K; Isogawa K; Akiyoshi J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):220-4. PubMed ID: 22063648
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression.
Lok A; Mocking RJ; Ruhé HG; Visser I; Koeter MW; Assies J; Bockting CL; Olff M; Schene AH
Psychoneuroendocrinology; 2012 Jul; 37(7):892-902. PubMed ID: 22094110
[TBL] [Abstract][Full Text] [Related]
16. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls.
Matsuzaka H; Maeshima H; Kida S; Kurita H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
Int J Psychiatry Med; 2013; 46(2):203-21. PubMed ID: 24552043
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features.
Karlović D; Serretti A; Vrkić N; Martinac M; Marčinko D
Psychiatry Res; 2012 Jun; 198(1):74-80. PubMed ID: 22386567
[TBL] [Abstract][Full Text] [Related]
20. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
